<?xml version='1.0' encoding='utf-8'?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2011//EN" "http://www.ncbi.nlm.nih.gov/entrez/query/DTD/pubmed_110101.dtd">
<pubmedarticleset>
 <pubmedarticle>
  <medlinecitation owner="NLM" status="MEDLINE">
   <pmid version="1">
    6529911
   </pmid>
   <datecreated>
    <year>
     1985
    </year>
    <month>
     05
    </month>
    <day>
     08
    </day>
   </datecreated>
   <datecompleted>
    <year>
     1985
    </year>
    <month>
     05
    </month>
    <day>
     08
    </day>
   </datecompleted>
   <daterevised>
    <year>
     2005
    </year>
    <month>
     11
    </month>
    <day>
     17
    </day>
   </daterevised>
   <article pubmodel="Print">
    <journal>
     <issn issntype="Print">
      0010-7824
     </issn>
     <journalissue citedmedium="Print">
      <volume>
       30
      </volume>
      <issue>
       6
      </issue>
      <pubdate>
       <year>
        1984
       </year>
       <month>
        Dec
       </month>
      </pubdate>
     </journalissue>
     <title>
      Contraception
     </title>
     <isoabbreviation>
      Contraception
     </isoabbreviation>
    </journal>
    <articletitle>
     Influence of removal of intrauterine contraceptive devices on colonisation of the cervix by actinomyces-like organisms.
    </articletitle>
    <pagination>
     <medlinepgn>
      535-44
     </medlinepgn>
    </pagination>
    <abstract>
     <abstracttext>
      An overall prevalence rate of actinomyces-like organisms (ALO) in cervical smears from intrauterine contraceptive device (IUCD) users of 3% (79/2, 734) was found, with a rate of 2% and 22.6% for copper and inert IUCD users. Although the users of the inert IUCDs were older, and their devices had been in situ longer, these factors did not account for the significant difference between the two types of IUCD. Fifty-five patients were counselled and given a leaflet on ALO. Fourteen IUCD users with ALO positive smears who had their devices removed had mild or moderate pelvic pain or discharge. Six others who were asymptomatic had the IUCD removed at their own request. All fifty-five patients were re-examined six months to one year later, and a smear was repeated. Only one woman required later removal of the IUCD because of dyspareunia with pelvic tenderness. After removal of the IUCD, and without antibiotic therapy, in 100% (20/20) of the women, ALO colonisation was no longer found six to twelve months later. This applied even to seven women who had had a new copper IUCD inserted immediately after removal of the index device.
     </abstracttext>
    </abstract>
    <authorlist completeyn="Y">
     <author validyn="Y">
      <lastname>
       Mao
      </lastname>
      <forename>
       K
      </forename>
      <initials>
       K
      </initials>
     </author>
     <author validyn="Y">
      <lastname>
       Guillebaud
      </lastname>
      <forename>
       J
      </forename>
      <initials>
       J
      </initials>
     </author>
    </authorlist>
    <language>
     eng
    </language>
    <publicationtypelist>
     <publicationtype>
      Journal Article
     </publicationtype>
    </publicationtypelist>
   </article>
   <medlinejournalinfo>
    <country>
     UNITED STATES
    </country>
    <medlineta>
     Contraception
    </medlineta>
    <nlmuniqueid>
     0234361
    </nlmuniqueid>
    <issnlinking>
     0010-7824
    </issnlinking>
   </medlinejournalinfo>
   <citationsubset>
    IM
   </citationsubset>
   <citationsubset>
    J
   </citationsubset>
   <meshheadinglist>
    <meshheading>
     <descriptorname majortopicyn="N">
      Actinomyces
     </descriptorname>
     <qualifiername majortopicyn="N">
      isolation &amp; purification
     </qualifiername>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Actinomycosis
     </descriptorname>
     <qualifiername majortopicyn="Y">
      microbiology
     </qualifiername>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Adult
     </descriptorname>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Cervix Uteri
     </descriptorname>
     <qualifiername majortopicyn="Y">
      microbiology
     </qualifiername>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Female
     </descriptorname>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Follow-Up Studies
     </descriptorname>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Humans
     </descriptorname>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Intrauterine Devices
     </descriptorname>
     <qualifiername majortopicyn="Y">
      adverse effects
     </qualifiername>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Intrauterine Devices, Copper
     </descriptorname>
     <qualifiername majortopicyn="N">
      adverse effects
     </qualifiername>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Middle Aged
     </descriptorname>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Pelvic Inflammatory Disease
     </descriptorname>
     <qualifiername majortopicyn="N">
      microbiology
     </qualifiername>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Uterine Cervicitis
     </descriptorname>
     <qualifiername majortopicyn="Y">
      microbiology
     </qualifiername>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Vaginal Smears
     </descriptorname>
    </meshheading>
   </meshheadinglist>
   <otherid source="PIP">
    028747
   </otherid>
   <otherid source="POP">
    00140320
   </otherid>
   <otherabstract type="PIP">
    <abstracttext>
     An overall prevalence rate of actinomyces-like organisms (ALO) in cervical smears of IUD users of 3% (79/2734) was found, with a rate of 2% and 22.6% for copper and inert IUD users.  Although the users of the inert IUDs were older, and their devices had been in situ longer, these factors did not account for the significant differences between the 2 types of IUD.  55 patients were counseled and given a leaflet on ALO.  14 IUD users with ALO positive smears who had their devices removed had mild or moderate pelvic pain or discharge.  6 others who were asymptomatic had the IUD removed at their own request.  All 55 patients were reexamined 6 months-1 year later and a smear was repeated.  Only 1 woman required later removal of the IUD because of dyspareunia with pelvic tenderness.  After IUD removal, and without antibiotic therapy, ALO colonization was no longer found 6-12 months later in 100% (20/20) of the cases.  This even included the 7 women who had had new copper IUDs inserted immediately after removal of the index device.
    </abstracttext>
   </otherabstract>
   <keywordlist owner="PIP">
    <keyword majortopicyn="Y">
     Bacterial And Fungal Diseases--complications
    </keyword>
    <keyword majortopicyn="Y">
     Communication
    </keyword>
    <keyword majortopicyn="Y">
     Contraception
    </keyword>
    <keyword majortopicyn="Y">
     Contraception Termination
    </keyword>
    <keyword majortopicyn="N">
     Contraceptive Methods
    </keyword>
    <keyword majortopicyn="N">
     Copper
    </keyword>
    <keyword majortopicyn="Y">
     Diseases
    </keyword>
    <keyword majortopicyn="Y">
     Examinations And Diagnoses
    </keyword>
    <keyword majortopicyn="N">
     Family Planning
    </keyword>
    <keyword majortopicyn="Y">
     Iec
    </keyword>
    <keyword majortopicyn="N">
     Infections
    </keyword>
    <keyword majortopicyn="N">
     Inorganic Chemicals
    </keyword>
    <keyword majortopicyn="Y">
     Iud
    </keyword>
    <keyword majortopicyn="Y">
     Laboratory Examinations And Diagnoses
    </keyword>
    <keyword majortopicyn="Y">
     Laboratory Procedures
    </keyword>
    <keyword majortopicyn="Y">
     Mass Media
    </keyword>
    <keyword majortopicyn="Y">
     Measurement
    </keyword>
    <keyword majortopicyn="N">
     Metals
    </keyword>
    <keyword majortopicyn="N">
     Organization And Administration
    </keyword>
    <keyword majortopicyn="Y">
     Pamphlets
    </keyword>
    <keyword majortopicyn="Y">
     Prevalence
    </keyword>
    <keyword majortopicyn="N">
     Printed Media
    </keyword>
    <keyword majortopicyn="N">
     Program Activities
    </keyword>
    <keyword majortopicyn="N">
     Programs
    </keyword>
    <keyword majortopicyn="N">
     Research Methodology
    </keyword>
    <keyword majortopicyn="N">
     Signs And Symptoms
    </keyword>
   </keywordlist>
   <generalnote owner="PIP">
    TJ: CONTRACEPTION.
   </generalnote>
  </medlinecitation>
  <pubmeddata>
   <history>
    <pubmedpubdate pubstatus="pubmed">
     <year>
      1984
     </year>
     <month>
      12
     </month>
     <day>
      1
     </day>
    </pubmedpubdate>
    <pubmedpubdate pubstatus="medline">
     <year>
      1984
     </year>
     <month>
      12
     </month>
     <day>
      1
     </day>
     <hour>
      0
     </hour>
     <minute>
      1
     </minute>
    </pubmedpubdate>
    <pubmedpubdate pubstatus="entrez">
     <year>
      1984
     </year>
     <month>
      12
     </month>
     <day>
      1
     </day>
     <hour>
      0
     </hour>
     <minute>
      0
     </minute>
    </pubmedpubdate>
   </history>
   <publicationstatus>
    ppublish
   </publicationstatus>
   <articleidlist>
    <articleid idtype="pubmed">
     6529911
    </articleid>
   </articleidlist>
  </pubmeddata>
 </pubmedarticle>
</pubmedarticleset>

